期刊
CA-A CANCER JOURNAL FOR CLINICIANS
卷 69, 期 4, 页码 305-343出版社
WILEY
DOI: 10.3322/caac.21560
关键词
biomarkers; cancer; gene expression profiling; drug target; molecular-targeted therapy; molecular profiling; mutation; precision medicine; sequence analysis
类别
The world of molecular profiling has undergone revolutionary changes over the last few years as knowledge, technology, and even standard clinical practice have evolved. Broad molecular profiling is now nearly essential for all patients with metastatic solid tumors. New agents have been approved based on molecular testing instead of tumor site of origin. Molecular profiling methodologies have likewise changed such that tests that were performed on patients a few years ago are no longer complete and possibly inaccurate today. As with all rapid change, medical providers can quickly fall behind or struggle to find up-to-date sources to ensure he or she provides optimum care. In this review, the authors provide the current state of the art for molecular profiling/precision medicine, practice standards, and a view into the future ahead.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据